Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FXRS4
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,943
Award facts
- Contract value 100% obligated
- $6,943.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $6,943.10 to DMS Pharmaceutical Group Inc. for the supply of Nexplanon 68 mg implants, a subdermal contraceptive device. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order is scheduled for completion by August 26, 2025, with performance to take place at the vendor's Park Ridge facility. This award represents a routine procurement action within DLA's pharmaceutical supply operations supporting Department of Defense healthcare facilities.
This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC framework enables DLA to issue firm fixed-price delivery orders for pharmaceutical products, medical supplies, and biologics required across military health facilities worldwide. DMS Pharmaceutical Group has established itself as a significant supplier within the federal pharmaceutical supply chain through consistent contract performance across a diverse portfolio of medical products, including prescription medications, over-the-counter items, vaccines, and specialty pharmaceuticals for defense healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FXRS4?
SPE2DB25FXRS4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 5, 2025.
How much is contract SPE2DB25FXRS4 worth?
The government has obligated $6,943 on SPE2DB25FXRS4.
Is contract SPE2DB25FXRS4 an order under another contract?
Yes. SPE2DB25FXRS4 is a delivery order under SPE2DB24D9131, an indefinite delivery contract.
Was contract SPE2DB25FXRS4 competed?
The extent of competition for SPE2DB25FXRS4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award